Genomenon

Ann Arbor, United States

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

$5.5M raised

May 2024

Venture - Series Unknown

Top Investors

University of MichiganNational Institutes of HealthSpring Mountain CapitalBeringeaMichigan Rise

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Genomenon raised?

Genomenon has raised $5.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are Genomenon's investors?

Genomenon's investors include University of Michigan, National Institutes of Health, Spring Mountain Capital, Beringea, Michigan Rise.

Where is Genomenon headquartered?

Genomenon is headquartered in Ann Arbor, United States.

What does Genomenon do?

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

What stage is Genomenon at?

Genomenon is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 16, 2024.

MLA

"Genomenon — Funding & Investors." VCBacked, May 16, 2024, https://www.vcbacked.co/company/genomenon. Accessed June 4, 2026.

APA

VCBacked. (2024). Genomenon — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/genomenon

Wikipedia (cite web)

{{cite web |title=Genomenon — Funding & Investors |url=https://www.vcbacked.co/company/genomenon |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 16, 2024.